We are live on ! Find out more
GRNA

GreenLight Biosciences Holdings, PBC Common Stock

Delisted

GRNA was delisted on the 21st of July, 2023.

68 hedge funds and large institutions have $173M invested in GreenLight Biosciences Holdings, PBC Common Stock in 2021 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 11

6% more capital invested

Capital invested by funds: $163M → $173M (+$9.8M)

0% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 15

3% less funds holding

Funds holding: 7068 (-2)

Holders
68
Holders Change
-2
Holders Change %
-2.86%
% of All Funds
1.05%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
15
Increased
14
Reduced
11
Closed
15
Calls
$496K
Puts
Net Calls
+$496K
Net Calls Change
+$496K
Name Holding Trade Value Shares
Change
Change in
Stake
USPCM
26
Union Square Park Capital Management
New York
$2.52M +$2.52M +253,770 New
WA
27
Whitebox Advisors
Minnesota
$2.19M
CCA
28
Castle Creek Arbitrage
Colorado
$1.98M
MI
29
MMCAP International
Cayman Islands
$1.98M
TIM
30
Timelo Investment Management
Ontario, Canada
$1.98M +$1.99M +200,000 New
AA
31
AQR Arbitrage
Connecticut
$1.86M
CL
32
CSS LLC
Illinois
$1.62M
WRBC
33
W.R. Berkley Corp
Connecticut
$1.55M
TCM
34
Tenor Capital Management
New York
$1.45M
Nomura Holdings
35
Nomura Holdings
Japan
$1.3M
YCM
36
Yakira Capital Management
Connecticut
$1.24M
VI
37
Vestcor Inc
New Brunswick, Canada
$1.12M
Toronto Dominion Bank
38
Toronto Dominion Bank
Ontario, Canada
$1.03M
LCM
39
Lynwood Capital Management
Ontario, Canada
$1.01M +$1.01M +102,076 New
Rockefeller Capital Management
40
Rockefeller Capital Management
New York
$952K +$218K +21,900 +30%
SSA
41
Schonfeld Strategic Advisors
New York
$927K -$1.45M -145,397 -61%
RCM
42
Radcliffe Capital Management
Pennsylvania
$890K
OAC
43
OMERS Administration Corp
Ontario, Canada
$783K +$785K +78,937 New
CI Investments Inc
44
CI Investments Inc
Ontario, Canada
$742K +$389K +39,100 +110%
NAM
45
Nexpoint Asset Management
Texas
$545K
CM
46
Crestline Management
Texas
$513K
CIM
47
Cowen Investment Management
New York
$496K -$1.99M -200,000 -80%
ACA
48
Arena Capital Advisors
California
$496K
DAM
49
Deltec Asset Management
New York
$496K
MA
50
MYDA Advisors
New York
$479K +$480K +48,300 New

GRNA Hedge Fund Activity: Q4 2021 in Review

68 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in GreenLight Biosciences Holdings, PBC Common Stock (GRNA) for Q4 2021, worth a combined $173M — up 6% from $163M a quarter earlier.

Fund positioning in GRNA was balanced in Q4 2021: 15 funds opened new positions, 15 closed out, 14 added to existing stakes and 11 trimmed.

The largest buyer was Marshall Wace, opening a new position worth an estimated $7.81M. The largest seller was Telemark Asset Management, exiting entirely with an estimated $5.93M sold.

  • 68 institutional investors held GreenLight Biosciences Holdings, PBC Common Stock (GRNA) as of Q4 2021, down from 70 in Q3 2021.
  • Funds reported $173M of GreenLight Biosciences Holdings, PBC Common Stock stock for Q4 2021, up 6% quarter-over-quarter.
  • 15 funds opened new GreenLight Biosciences Holdings, PBC Common Stock positions in Q4 2021 and 15 closed out, a net change of 0 holders.
  • The largest GreenLight Biosciences Holdings, PBC Common Stock buyer in Q4 2021 was Marshall Wace, an estimated $7.81M added.
  • The largest GreenLight Biosciences Holdings, PBC Common Stock seller in Q4 2021 was Telemark Asset Management, an estimated $5.93M sold.

Based on aggregated 13F filings for Q4 2021.